PDF(1466 KB)
PDF(1466 KB)
PDF(1466 KB)
制度创业视角下药品供应链数字化重构能力形成机制研究
Formation mechanism of digital reconstruction capability in pharmaceutical supply chain:An institutional entrepreneurship perspective
在数字经济时代,药品供应链数字化重构能力已成为互联网医疗企业建立竞争优势的重要基础,如何通过数字技术耦合获取新制度合法性并驱动动态能力形成值得深入研究。本文以京东健康和阿里健康为例,采用双案例研究方法深入探讨数字技术耦合在药品供应链数字化重构中的作用机制。研究发现:(1)数字技术在药品供应链中的耦合应用,通过培育企业敏捷响应与协同共创的双元能力,形成药品供应链数字化重构的动态能力体系;(2)纵深集成式和开放分布式数字技术耦合逻辑塑造了企业动态能力培育的差异化路径;(3)药品供应链数字化重构揭示了新兴场域下企业制度压力应对与新制度建构的共演机制,互联网医疗企业通过与多元制度参与者互动构建了规制、规范、认知合法性,其中数字技术应用加快了制度合法性的获取进程。本文拓展了动态能力理论与制度创业理论在新兴数字情境下的适用边界,为药品供应链数字化转型提供理论框架与管理启示。
In the digital economy era,the digital reconstruction capability of pharmaceutical supply chains has become a critical foundation for internet-based healthcare enterprises to establish competitive advantages. The mechanism through which digital technology coupling facilitates the acquisition of new institutional legitimacy and drives the formation of dynamic capabilities warrants in-depth investigation. This study adopted a dual-case research approach,focusing on JD Health and AliHealth,to systematically explore the role of digital technology coupling in the digital reconstruction of pharmaceutical supply chains. The research revealed three key insights:(1) The coupling application of digital technologies in pharmaceutical supply chains cultivates enterprises' ambidextrous capabilities—agile responsiveness and collaborative co-creation—thereby forming a dynamic capability system for digital reconstruction; (2) The logic of vertically integrated and openly distributed digital technology coupling shapes differentiated pathways for dynamic capability development; (3) The digital reconstruction of pharmaceutical supply chains demonstrates a co-evolutionary mechanism between institutional pressure response and new institutional construction in emerging fields. Internet-based healthcare enterprises construct regulatory,normative,and cognitive legitimacy through interactions with multiple institutional actors,with digital technologies significantly accelerating the legitimacy acquisition process. This study extends the theoretical boundaries of dynamic capability theory and institutional entrepreneurship in digital contexts,and will provide a conceptual framework and managerial insights for the digital transformation of pharmaceutical supply chains.
药品供应链 / 数字化重构能力 / 数字技术耦合 / 制度创业 / 双案例研究
pharmaceutical supply chain / digital reconfiguration ability / digital technology coupling / institutional entrepreneurship / dual case study
| [1] |
王静. 中国供应链生态系统发展质量提升机制研究[J]. 中国软科学, 2024(6):33-42.
|
| [2] |
孙新波, 钱雨, 张明超, 等. 大数据驱动企业供应链敏捷性的实现机理研究[J]. 管理世界, 2019, 35(9):133-151+200.
|
| [3] |
|
| [4] |
张振刚, 户安涛, 叶宝升. 制造企业数字创新与能力重构的过程机理研究[J]. 科研管理, 2024, 45(4):20-31.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
宋华, 韩梦玮, 沈凌云. 人工智能在供应链韧性塑造中的作用:基于迈创全球售后供应链管理实践的案例研究[J]. 中国工业经济, 2024(5):174-192.
|
| [9] |
钱晶晶, 何筠. 传统企业动态能力构建与数字化转型的机理研究[J]. 中国软科学, 2021(6):135-143.
|
| [10] |
|
| [11] |
袁业虎, 孙晏平. 供应链核心企业数字化转型对中小企业创新的影响和机制[J]. 科研管理, 2024, 45(6):12-21.
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
毛基业. 运用结构化的数据分析方法做严谨的质性研究:中国企业管理案例与质性研究论坛(2019)综述[J]. 管理世界, 2020, 36(3):221-227.
|
| [19] |
|
| [20] |
|
/
| 〈 |
|
〉 |